Novo Nordisk A/S - ROE

The ROE as of September 2026 (TTM) for Novo Nordisk A/S (NOV.DE) is 59.09%

According to Novo Nordisk A/S’s latest financial reports and current stock price. The company's current ROE is 59.09%. This represents a change of 300.38% compared to the average of 14.76% of the last 4 quarters.

Novo Nordisk A/S (NOV.DE) Historical ROE (quarterly & annually)

How has NOV.DE ROE performed in the past?

The mean historical ROE of Novo Nordisk A/S over the last ten years is 70.47%. The current 59.09% ROE has changed -16.16% with respect to the historical average. Over the past ten years (40 quarters), NOV.DE's ROE was at its highest in in the March 2024 quarter at 25.69%. The ROE was at its lowest in in the June 2026 quarter at 9.49%.

Novo Nordisk A/S (NOV.DE) ROE by Quarter and Year

Discovering the peaks and valleys of Novo Nordisk A/S ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Novo Nordisk A/S (NOV.DE) Average ROE

How has NOV.DE ROE performed in the past?

The current ROE of Novo Nordisk A/S (NOV.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Novo Nordisk A/S (NOV.DE) ROE vs. Peers

How is NOV.DE’s ROE compared to its peers?

Novo Nordisk A/S’s ROE is less than Abbott Laboratories (10.52%), less than Merck & Co., Inc. (6.60%), less than Thermo Fisher Scientific Inc. (13.35%), less than AstraZeneca PLC (21.68%), less than Vertex Pharmaceuticals Incorporated (23.31%), less than Pfizer Inc. (4.89%), less than Pfizer Inc. (4.89%), greater than Gilead Sciences, Inc. (-16.28%), less than Amgen Inc. (89.32%), less than UnitedHealth Group Incorporated (14.63%),

Build a custom stock screener for Novo Nordisk A/S (NOV.DE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novo Nordisk A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novo Nordisk A/S (NOV.DE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novo Nordisk A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.